QIAGEN N.V. QGEN recently added two new nucleic acid extraction kits, extending its eco-friendly QIAwave product line. The two new kits are the QIAwave RNeasy Plus Mini Kit and the QIAwave DNA/RNA ...

QIAGEN dramatically ramping up global production capacity for RNA extraction kits for use in detection of SARS-CoV-2 coronavirus ...

The QIAwave RNeasy Plus Mini Kit is a new generation of RNA extraction that enables the isolation of high-purity and high-yield total RNA with an integrated gDNA removal from a wide range of ...

The extracted RNA can then go on to the RT-PCR step. Qiagen, based in the Netherlands, is one of largest of the companies that makes RNA extraction kits.

The growth in the cell-free RNA isolation and extraction kits market is expected to be driven by an increasing number of kits and a rising number of open-source free sequencing platform providers ...

Qiagen has announced the launch of AllPrep DNA/RNA Mini Kit, designed to purifie both genomic DNA and total RNA from a single cell or tissue sample. Since the sample is not divided into two for ...

Omega Bio-tek Launches a New Viral RNA Extraction Kit for COVID-19 Testing with Production Capacity for 6 Million Tests A Month.

* QIAGEN NV - RAMPING UP GLOBAL PRODUCTION CAPACITY FOR RNA EXTRACTION KITS FOR USE IN DETECTION OF SARS-COV-2 CORONAVIRUS Sign up here. * QIAGEN - RAMPING UP PRODUCTION CAPACITY FOR REAGENTS TO ...

QIAGEN N.V. QGEN recently added two new nucleic acid extraction kits, extending its eco-friendly QIAwave product line. The two new kits are the QIAwave RNeasy Plus Mini Kit and the QIAwave DNA/RNA ...

QIAGEN has historically allocated global production capacity to manufacture RNA nucleic extraction reagents to supply about 1.5 million patient tests on a monthly basis.

Goal to reach global capacity for RNA nucleic extraction workflows for over 10 million patient tests a month by end of June 2020 and to reach capacity for 20 million monthly patient tests by end of ...